FDA repays drug industry by rushing risky meds to market
As pharma companies underwrite three-fourths of the U.S. Food and Drug Administration’s budget for scientific reviews, the agency is increasingly fast-tracking expensive drugs with significant side effects and unproven health benefits.
via FOX NEWS http://foxnews.com/health/2018/07/01/fda-repays-drug-industry-by-rushing-risky-meds-to-market.html
No comments:
Post a Comment